People: Neurocrine Biosciences Inc (NBIX.O)

NBIX.O on Nasdaq

19 Dec 2014
Price Change (% chg)

$0.59 (+2.47%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Grigoriadis, Dimitri 

Brief Biography

Dr. Dimitri E. Grigoriadis, Ph.D., is Chief Research Officer of Neurocrine Biosciences Inc., since January 2007. He oversees all research functions including drug discovery, biology and chemistry. Dr. Grigoriadis joined Neurocrine in 1993, established the Pharmacology and drug screening groups and was most recently a Neurocrine Fellow and Vice President of Discovery Biology. Prior to joining Neurocrine, he was a Senior Scientist in the Neuroscience group at the DuPont Pharmaceutical Company from 1990 to 1993. Dr. Grigoriadis received his B.Sc. from the University of Guelph in Ontario, Canada, and his M.Sc. and Ph.D. in Pharmacology from the University of Toronto, Ontario, Canada. He conducted his postdoctoral research at the National Institute on Drug Abuse from 1987 to 1990.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
409,900 -- 506,199 1,028,550

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 75,674 743,167.00
Name Fiscal Year Total

William Rastetter


Kevin Gorman


Timothy Coughlin


Haig Bozigian


Dimitri Grigoriadis


Darin Lippoldt

As Of 30 Dec 2013
Search Stocks